207 related articles for article (PubMed ID: 8137105)
1. D2 dopamine receptor binding in the basal ganglia of antipsychotic-free schizophrenic patients. An 123I-IBZM single photon emission computerised tomography study.
Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Murray RM; Kerwin RW
Br J Psychiatry; 1994 Jan; 164(1):16-26. PubMed ID: 8137105
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic medication, D2 dopamine receptor blockade and clinical response: a 123I IBZM SPET (single photon emission tomography) study.
Pilowsky LS; Costa DC; Ell PJ; Murray RM; Verhoeff NP; Kerwin RW
Psychol Med; 1993 Aug; 23(3):791-7. PubMed ID: 7901865
[TBL] [Abstract][Full Text] [Related]
3. Stereotypy, schizophrenia and dopamine D2 receptor binding in the basal ganglia.
Pedro BM; Pilowsky LS; Costa DC; Hemsley DR; Ell PJ; Verhoeff NP; Kerwin RW; Gray NS
Psychol Med; 1994 May; 24(2):423-9. PubMed ID: 8084937
[TBL] [Abstract][Full Text] [Related]
4. Dopamine D2 receptor occupancy measured by single photon emission computed tomography with 123I-Iodobenzamide in chronic schizophrenia.
Volk S; Maul FD; Hör G; Schreiner M; Weppner M; Holzmann T; Pflug B
Psychiatry Res; 1994 Jun; 55(2):111-8. PubMed ID: 10711799
[TBL] [Abstract][Full Text] [Related]
5. A single photon emission computed tomography scan study of striatal dopamine D2 receptor binding with 123I-epidepride in patients with schizophrenia and controls.
Tibbo P; Silverstone PH; McEwan AJ; Scott J; Joshua A; Golberg K
J Psychiatry Neurosci; 1997 Jan; 22(1):39-45. PubMed ID: 9002391
[TBL] [Abstract][Full Text] [Related]
6. [123I]IBZM SPECT for imaging of striatal D2 dopamine receptors in 56 schizophrenic patients taking various neuroleptics.
Klemm E; Grünwald F; Kasper S; Menzel C; Broich K; Danos P; Reichmann K; Krappel C; Rieker O; Briele B; Hotze AL; Möller HJ; Biersack HJ
Am J Psychiatry; 1996 Feb; 153(2):183-90. PubMed ID: 8561197
[TBL] [Abstract][Full Text] [Related]
7. Gender differences in D2 dopamine receptor binding in drug-naive patients with schizophrenia: an [123I]iodobenzamide single photon emission computed tomography study.
Schröder J; Bubeck B; Silvestri S; Demisch S; Sauer H
Psychiatry Res; 1997 Sep; 75(2):115-23. PubMed ID: 9351493
[TBL] [Abstract][Full Text] [Related]
8. [Dopamine (D2) receptor SPECT with 123I-iodobenzamide (IBZM) in diagnosis of Parkinson syndrome].
Reiche W; Grundmann M; Huber G
Radiologe; 1995 Nov; 35(11):838-43. PubMed ID: 8657887
[TBL] [Abstract][Full Text] [Related]
9. Association between cognitive performance and striatal dopamine binding is higher in timing and motor tasks in patients with schizophrenia.
Yang YK; Yeh TL; Chiu NT; Lee IH; Chen PS; Lee LC; Jeffries KJ
Psychiatry Res; 2004 Sep; 131(3):209-16. PubMed ID: 15465290
[TBL] [Abstract][Full Text] [Related]
10. Iodine-123-iodobenzamide SPECT assessment of dopamine D2 receptor occupancy in riperidone-treated schizophrenic patients.
Dresel S; Tatsch K; Dähne I; Mager T; Scherer J; Hahn K
J Nucl Med; 1998 Jul; 39(7):1138-42. PubMed ID: 9669383
[TBL] [Abstract][Full Text] [Related]
11. Latent inhibition in drug naive schizophrenics: relationship to duration of illness and dopamine D2 binding using SPET.
Gray NS; Pilowsky LS; Gray JA; Kerwin RW
Schizophr Res; 1995 Sep; 17(1):95-107. PubMed ID: 8541255
[TBL] [Abstract][Full Text] [Related]
12. In vivo effects of olanzapine on striatal dopamine D(2)/D(3) receptor binding in schizophrenic patients: an iodine-123 iodobenzamide single-photon emission tomography study.
Dresel S; Mager T; Rossmüller B; Meisenzahl E; Hahn K; Möller HJ; Tatsch K
Eur J Nucl Med; 1999 Aug; 26(8):862-8. PubMed ID: 10436199
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopamine D2 receptor density in neuroleptic-naive and in neuroleptic-free schizophrenic patients: an 123I-IBZM-SPECT study.
Lomeña F; Catafau AM; Parellada E; Bernardo M; Font M; Gutiérrez F; Pavía J
Psychopharmacology (Berl); 2004 Mar; 172(2):165-9. PubMed ID: 14624330
[TBL] [Abstract][Full Text] [Related]
14. In vivo 123I IBZM SPECT imaging of striatal dopamine-2 receptor occupancy in schizophrenic patients treated with olanzapine in comparison to clozapine and haloperidol.
Tauscher J; Küfferle B; Asenbaum S; Fischer P; Pezawas L; Barnas C; Tauscher-Wisniewski S; Brücke T; Kasper S
Psychopharmacology (Berl); 1999 Jan; 141(2):175-81. PubMed ID: 9952042
[TBL] [Abstract][Full Text] [Related]
15. Single photon emission tomography assessment of cerebral dopamine D2 receptor blockade in schizophrenia.
Geaney DP; Ellis PM; Soper N; Shepstone BJ; Cowen PJ
Biol Psychiatry; 1992 Aug; 32(3):293-5. PubMed ID: 1358229
[No Abstract] [Full Text] [Related]
16. Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study.
Busatto GF; Pilowsky LS; Costa DC; Ell PJ; Verhoeff NP; Kerwin RW
Psychopharmacology (Berl); 1995 Jan; 117(1):55-61. PubMed ID: 7536945
[TBL] [Abstract][Full Text] [Related]
17. Dopamine D2 receptor occupancy in vivo by the novel atypical antipsychotic olanzapine--a 123I IBZM single photon emission tomography (SPET) study.
Pilowsky LS; Busatto GF; Taylor M; Costa DC; Sharma T; Sigmundsson T; Ell PJ; Nohria V; Kerwin RW
Psychopharmacology (Berl); 1996 Mar; 124(1-2):148-53. PubMed ID: 8935810
[TBL] [Abstract][Full Text] [Related]
18. Lack of sex differences in striatal dopamine D2 receptor binding in drug-naive schizophrenic patients: an IBZM-SPECT study.
Parellada E; Lomeña F; Catafau AM; Bernardo M; Font M; Fernández-Egea E; Pavía J; Gutierrez F
Psychiatry Res; 2004 Jan; 130(1):79-84. PubMed ID: 14972370
[TBL] [Abstract][Full Text] [Related]
19. Multivariate cluster analysis of dynamic iodine-123 iodobenzamide SPET dopamine D2 receptor images in schizophrenia.
Acton PD; Pilowsky LS; Costa DC; Ell PJ
Eur J Nucl Med; 1997 Feb; 24(2):111-8. PubMed ID: 9021106
[TBL] [Abstract][Full Text] [Related]
20. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
